Ketamine Addiction Treatment

Leczenie uzależnienia od ketaminy- powikłania psychiczne i specjalistyczna opieka kliniczna
Wnętrze ośrodka leczenia uzależnień prezentujące uporządkowany proces opieki klinicznej

Ketamine Addiction Treatment

Confidential residential treatment for ketamine addiction provided under continuous medical and psychiatric supervision. Treatment focuses on psychological stabilisation, the management of neurological and urological complications, and structured therapeutic work on the mechanisms of addiction in a safe clinical environment.

As part of our clinical approach to depressant and dissociative substance addiction treatment, we offer an individualised inpatient programme for patients whose ketamine use has become compulsive, psychologically destabilising or associated with significant medical harm. All clinical contact is confidential and non-binding.

What is ketamine?

Ketamine is a synthetic psychoactive substance originally used in medicine as an anaesthetic agent. Outside clinical settings, it is sometimes used recreationally because of its dissociative, hallucinogenic and analgesic effects.

In non-medical use, ketamine carries a high addictive potential, especially on the psychological level, and is associated with a substantial risk of neurological and physical complications. One of the most clinically distinctive features of problematic ketamine use is that dependence may develop alongside persistent dissociation, emotional detachment, cognitive impairment and progressive urinary tract damage.

Ketamine addiction as a clinical disorder

Ketamine addiction is a behavioural and substance-related disorder characterised by compulsive reaching for the substance, loss of control over dose and frequency, tolerance requiring progressively higher amounts, and continued use despite physical, neurological and psychological harm. A particularly important feature of ketamine addiction is the rapid development of psychological dependence together with a high risk of relapse.

Patients may initially use ketamine to escape emotional pain, dampen anxiety, interrupt distress or seek altered states of consciousness. Over time, the substance stops functioning as a chosen coping strategy and becomes a central factor in the worsening of psychiatric and social functioning.

When urgent medical attention is required

Urgent medical attention is required if, during withdrawal or after recent use, any of the following occur: seizures, loss of consciousness, severe disorientation, symptoms of psychosis, aggressive behaviour disproportionate to the situation, severe chest pain, shortness of breath or suspected overdose. In these situations, no attempt should be made to manage the condition independently. The priority is patient safety and rapid clinical assessment. In any life-threatening or health-threatening situation, emergency medical services should be contacted immediately by calling 112.

How ketamine affects the brain

Ketamine acts mainly as an NMDA receptor antagonist, affecting glutamatergic transmission in the brain. This may lead to derealisation, depersonalisation, altered perception of time and body, and a pronounced sense of detachment from emotions and external reality.

With longer-term use, ketamine may contribute to impaired neuroplasticity, worsening memory and concentration, mood destabilisation, and increased risk of psychotic and anxiety-related symptoms. In some patients, dissociative symptoms begin to persist beyond the acute effects of intoxication and interfere with everyday psychological functioning.

Symptoms of ketamine addiction

Psychological symptoms

  • derealisation and depersonalisation
  • memory and concentration impairment
  • anxiety, irritability and mood instability
  • depressive episodes
  • impulsivity
  • psychotic symptoms at higher doses

Physical symptoms

  • sleep disturbance
  • nausea and vomiting
  • abdominal pain
  • chronic fatigue
  • impaired motor coordination

Behavioural symptoms

  • social withdrawal
  • using ketamine as a form of emotional escape
  • neglect of responsibilities
  • polysubstance use, including combination with alcohol, MDMA or stimulants

Serious health complications associated with ketamine

Long-term ketamine use may lead to ketamine bladder syndrome, severe bladder damage, chronic inflammation of the urinary tract, kidney dysfunction, neurological impairment, lasting cognitive changes and increased risk of self-harm. Urological complications are among the most distinctive and serious consequences of chronic ketamine use and may become irreversible if treatment is not introduced early enough.

Because ketamine use often combines dissociative symptoms with substantial somatic risk, treatment should not focus narrowly on cessation alone. It requires integrated psychiatric, medical and functional assessment.

Ketamine addiction treatment at Zeus Detox & Rehab

Treatment is provided in a residential model with full medical and psychiatric supervision. Because of ketamine’s complex neuropsychiatric profile, treatment should be carried out within a structured drug addiction treatment setting under clinical conditions. The aim is to interrupt compulsive ketamine use, stabilise the patient’s psychological state, and address physical and psychiatric complications in a coordinated way.

Stages of ketamine addiction treatment

Treatment of ketamine addiction at Zeus Detox & Rehab usually proceeds through four main clinical stages.

Stage 1 - Clinical qualification and assessment

The process begins with psychiatric consultation including assessment of cognitive functioning, evaluation of anxiety and depressive disorders, a detailed substance use history, and laboratory and urological investigations where clinically indicated.

Stage 2 - Stabilisation and detoxification

Detoxification after ketamine includes psychological stabilisation, regulation of sleep and internal tension, treatment of anxiety and dissociative symptoms, monitoring of physical functioning and round-the-clock medical supervision.

Stage 3 - Addiction therapy

Once stabilisation has been achieved, individual psychotherapy is introduced. This phase includes work on emotional regulation, treatment of derealisation and depersonalisation symptoms, relapse prevention therapy and treatment of co-occurring psychiatric disorders.

Stage 4 - Planning of further care

The process also includes preparation of a post-discharge treatment plan, relapse prevention measures and coordination of outpatient therapy or further residential care where needed.

Detoxification after ketamine may be associated with severe psychological symptoms, including derealisation, depersonalisation, anxiety or psychotic symptoms. In cases of marked psychological destabilisation or safety risk, the patient may require treatment in an acute hospital setting.

When inpatient treatment for ketamine addiction may be indicated

For whom residential treatment may be appropriate

  • patients with compulsive ketamine use
  • derealisation, anxiety or depressive symptoms
  • urological or neurological complications
  • polysubstance addiction
  • ineffective outpatient treatment
  • deterioration in psychosocial functioning

When another level of care is necessary

  • acute life-threatening condition
  • need for hospitalisation in an acute unit
  • lack of consent to inpatient treatment

Every case is qualified individually.

Scope of treatment and clinical responsibility

Residential treatment focuses on medical stabilisation, evaluation of the patient’s psychological state and intensive therapeutic work in the acute or advanced phase of the disorder. It does not replace long-term outpatient treatment and does not guarantee any specific clinical outcome. Planning of further care is an integral part of the therapeutic process.

FAQ

Is ketamine addictive?
Yes. Ketamine may lead to strong psychological dependence and to serious long-term complications, especially affecting mental functioning and the urinary tract.
Does treatment require a residential stay?
In cases of pronounced psychological symptoms or significant physical complications, yes. Inpatient treatment may provide the level of stabilisation and safety that outpatient treatment cannot.
Can ketamine damage the bladder?
Yes. Long-term ketamine use may lead to severe and sometimes irreversible bladder damage, including ketamine bladder syndrome.
Is treatment confidential?
Yes. The entire treatment process is covered by medical confidentiality.
How long does treatment last?
Duration is always determined individually, depending on the patient’s clinical condition, psychological symptoms, physical complications and response to treatment.
Schody w ośrodku leczenia z dużymi oknami i widokiem na zieleń
Ośrodek leczenia stacjonarnego z lotu ptaka w otoczeniu zieleni
logo zeus detox & rehab

Confidential Clinical Contact

CLINICAL INQUIRY

The form is intended for submitting a clinical inquiry. Messages are delivered directly to the team responsible for treatment coordination.

Related Treatment Areas

Clinical Contact

Contact with the center is intended for providing information regarding inpatient treatment and coordinating next steps in a confidential and non-binding manner.

Scope of Treatment and Informational Nature of Content

Inpatient treatment provided at Zeus Detox & Rehab is clinical in nature and focuses on medical stabilization, psychiatric assessment, and therapeutic intervention appropriate to the diagnosed condition and stage of the disorder. The scope and structure of treatment are determined individually by the clinical team based on the patient’s current health status and applicable medical standards.

The information presented on this website is for educational and informational purposes only. It does not constitute medical advice and should not be used as a basis for self-directed treatment decisions. Addiction and mental health treatment require individual medical qualification and clinical assessment.

Content Author

Content published on this website is prepared by the interdisciplinary clinical team of Zeus Detox & Rehab in collaboration with physicians, psychiatrists, psychotherapists, clinical psychologists, and medical staff. Materials are developed on the basis of current medical knowledge and clinical experience in inpatient addiction treatment.